REGISTER NOW

The EpiSensA method has recently been included in OECD test guidelines for dermal sensitization assessment. Because it is conducted using a three-dimensional epidermal tissue model, the assay offers benefits over traditional cell culture methods. Join us to learn more about the assay, how it is conducted, and the laboratory transferability process. A Q&A discussion will follow both presentations.

Presentation 1: Hiromichi Mitake, Japan Tissue Engineering Co., Ltd
“Fundamentals of EpiSensA and Evaluation of the Effects of EPI-MODEL24 Storage Stability on Assays”
This session will provide an overview of the EpiSensA assay, covering everything from basic procedures to prediction methods. Evaluation results regarding the impact of EPI-MODEL24 storage stability on assay performance will also be shared. These insights aim to assist practitioners in maintaining test quality and ensuring highly reproducible data.

Presentation 2: Meera Ramani, Institute for In Vitro Sciences
“EpiSensA Technology Transfer: Navigating the Winding Roads Through Effective Optimization and Troubleshooting”
This presentation will discuss the successful transfer of the EpiSensA assay to IIVS, highlighting the importance of shipping studies, procedural refinements, trouble shooting and optimization of targeted assay steps, and proficiency testing in achieving assay readiness.